CapsoVision (NASDAQ:CV) Major Shareholder Buys $410,987.64 in Stock

CapsoVision, Inc. (NASDAQ:CV) major shareholder Eliyahou Et Al Harari acquired 61,068 shares of CapsoVision stock in a transaction on Friday, July 17th. The shares were bought at an average cost of $6.73 per share, with a total value of $410,987.64. Following the completion of the purchase, the insider owned 3,343,119 shares in the company, valued at $22,499,190.87. The trade was a 1.86% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Eliyahou Et Al Harari also recently made the following trade(s):

• On Wednesday, July 8th, Eliyahou Et Al Harari bought 81,300 shares of CapsoVision stock. The stock was bought at an average price of $6.09 per share, for a total transaction of $495,117.00.
• On Friday, June 26th, Eliyahou Et Al Harari bought 13,850 shares of CapsoVision stock. The stock was bought at an average cost of $7.35 per share, for a total transaction of $101,797.50.

CapsoVision Price Performance

CapsoVision stock opened at $6.70 on Friday. The business has a 50 day simple moving average of $6.78 and a 200-day simple moving average of $6.28. CapsoVision, Inc. has a 12 month low of $3.43 and a 12 month high of $15.37. The stock has a market capitalization of $334.76 million and a PE ratio of -2.86.

CapsoVision (NASDAQ:CV) last posted its quarterly earnings data on Thursday, May 14th. The company reported ($0.15) earnings per share for the quarter. The company had revenue of $2.79 million for the quarter.

Institutional Investors Weigh In On CapsoVision

A number of institutional investors and hedge funds have recently modified their holdings of the company. Deutsche Bank AG purchased a new position in CapsoVision in the 4th quarter valued at approximately $47,000. Wells Fargo & Company MN grew its holdings in CapsoVision by 66.4% in the fourth quarter. Wells Fargo & Company MN now owns 6,287 shares of the company’s stock valued at $67,000 after purchasing an additional 2,508 shares during the last quarter. Citadel Advisors LLC purchased a new position in shares of CapsoVision in the third quarter valued at $115,000. Virtu Financial LLC acquired a new position in shares of CapsoVision during the 4th quarter worth $128,000. Finally, Bank of America Corp DE raised its stake in shares of CapsoVision by 528.9% during the 1st quarter. Bank of America Corp DE now owns 22,238 shares of the company’s stock worth $162,000 after buying an additional 18,702 shares during the last quarter.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of CapsoVision in a research note on Monday, June 29th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $8.50.

CapsoVision Company Profile

CapsoVision, Inc (NASDAQ: CV) is a medical device company specializing in advanced capsule endoscopy systems for gastrointestinal diagnostics. The company’s flagship product, the CapsoCam® Plus System, features a swallowable, tether-free capsule equipped with four side-viewing cameras that capture high-resolution, 360-degree images of the small intestine. By storing images internally rather than transmitting data wirelessly, CapsoCam Plus enables patients to maintain normal daily activities during the procedure and reduces the risk of signal loss or image drop-out.

In addition to its capsule hardware, CapsoVision offers CapsoCloud®, a secure, cloud-based platform that streamlines image retrieval, storage and reporting.